Evidence map›Paper›PMID 32448136›Full record

Trial reportBMC medical imaging2020

Application of CareDose 4D combined with Karl 3D technology in the low dose computed tomography for the follow-up of COVID-19.

Jiawei Li, Xiao Wang, Xiaolu Huang, Fangxing Chen, Xuesong Zhang, Ying Liu, Guangzuo Luo, Xunhua Xu

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC medical imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiawei LiDepartment of Radiology, China Resources & WISCO General Hospital, Wuhan, 430080, China.
Xiao WangDepartment of Radiology, China Resources & WISCO General Hospital, Wuhan, 430080, China.
Xiaolu HuangDepartment of Radiology, China Resources & WISCO General Hospital, Wuhan, 430080, China.
Fangxing ChenDepartment of Radiology, China Resources & WISCO General Hospital, Wuhan, 430080, China.
Xuesong ZhangDepartment of Radiology, China Resources & WISCO General Hospital, Wuhan, 430080, China.
Ying LiuDepartment of Biochemistry and Molecular Biology, China Medical University, Shenyang, 110122, China.
Guangzuo LuoInstitute of Translational Medicine, China Medical University, Shenyang, 110122, China. gzluo@cmu.edu.cn.ORCID 0000-0002-8518-5766
Xunhua XuDepartment of Radiology, China Resources & WISCO General Hospital, Wuhan, 430080, China. xxhwh@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) is a highly infectious disease caused by the new coronavirus. Previous studies have shown that the chest CT examination plays an important role in the diagnosis and monitoring of COVID-19. However, some patients with COVID-19 had low white blood cell counts and reduced lymphocyte ratios. Multiple CT examinations may cause radiation damages as well as increase the apoptosis of peripheral blood lymphocytes. A new low-dose CT method should be developed because the regular CT may aggravate the disease.

methodSixty cases were randomly divided into the study group (n = 30) and control group (n = 30). The lung window was reconstructed by Karl 3D iterative technique in the study group. The image quality was subjectively evaluated by two senior chest group diagnostic physicians using a 5-point double-blind method. The value of CT measurement and its standard deviation (SD) was used as an objective evaluation criteria. The volume of CT dose index (CTDI

resultThere was no significant difference in the occurrence rates of ground glass opacities, consolidation, crazy-paving pattern, fiber cable shadow and axial interstitial thickening between the study group and control group (p > 0.05). In addition, no significant difference was found for the subjective score of overall image quality and image noise level (SD) between the two groups (p > 0.05). However, significant differences was found in CTDI

conclusionCareDose 4D low-dose scanning combined with Karl 3D iterative reconstruction technology can not only greatly reduce the radiation dose, but also provide images that meet the diagnostic criteria of COVID-19, which can be used as a routine method for the follow-up of COVID-19 patients.

Indexed as

AdultAgedAged, 80 and overBetacoronavirusCoronavirus InfectionsCOVID-19Double-Blind MethodFemaleFour-Dimensional Computed TomographyHumansLungMaleMiddle AgedPandemicsPneumonia, ViralRadiation DosageCareDose 4DCOVID-19Image qualityRadiation dose

Identifiers

PMID32448136
PMCPMC7245769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.